Análisis
Análisis en profundidad de mercados farmacéuticos, cadenas de suministro, tecnología y regulación
#KOSDAQ ×
Análisis
21 sept 2026•1 min de lectura
BaroPharm Submits Securities Filing, Begins KOSDAQ IPO Process
BaroPharm filed a securities report with the Financial Services Commission and announced a public offering of 1.78 million shares, targeting a 16,400‑22,200 KRW price range, aiming for a KOSDAQ listing this year.
Análisis
16 sept 2026•1 min de lectura
Sky Labs Lists on KOSDAQ, Plans Expansion of Cuffless Blood Pressure Platform
Sky Labs has debuted on KOSDAQ, aiming to grow its ring‑type cuffless blood‑pressure monitor domestically and abroad while targeting a broader multi‑bio‑signal medical data platform.
Análisis
30 ago 2026•1 min de lectura
Sky Labs Announces KOSDAQ IPO, Plans to Offer 2 Million Shares
Sky Labs submitted its securities filing to the Financial Services Commission and began its public offering, targeting 2 million shares at KRW 13,000‑16,000 each.